ENDRA Life Sciences Inc. (NDRA) Dividend History

ENDRA Life Sciences Inc. (NDRA) is a medical technology company focused on developing and commercializing non-invasive imaging solutions. Its platform utilizes ultrasound and thermometry technology to provide innovative imaging options for medical professionals, particularly in the fields of liver health and other disease diagnostics. The company aims to improve patient care through advanced, cost-effective imaging methods.

3600 Green Court, Ann Arbor, MI, 48105
Phone: 734-335-0468
Website: https://www.endrainc.com

Dividend History

ENDRA Life Sciences Inc. currently does not pay dividends

Company News

  • What 3 Factors Impact Penny Stocks Prices the Most

    Here are the 3 factors that impact penny stocks more than others The post What 3 Factors Impact Penny Stocks Prices the Most appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AGRI MBIO
  • Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

    Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Vast Renewables Limited (NASDAQ: VSTE) rose 213.9% to $9.70 in pre-market trading after jumping 39% on Thursday. MediaCo Holding Inc. (NASDAQ: MDIA) gained 84% to $0.9601 in pre-market trading after dipping more than 17% on Thursday. Galera Therapeutics, Inc. (NASDAQ: GRTX) gained 49.5% to $0.2093 in pre-market trading. Galera Therapeutics posted fourth-quarter results on Thursday. Qilian International Holding Group Limited (NASDAQ: QLI) shares gained 32.2% to $0.8399 in pre-market trading. Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 30.7% to $0.0791 in pre-market trading after the company reported operating results for the fiscal year ended Dec. 31, 2023. Xilio Therapeutics, Inc. (NASDAQ: XLO) shares rose 26.8% to $1.37 in pre-market ...

    Benzinga
    Featured Companies: APLT AVTX CLSK CURV GUTS MDIA OXM PAVM SBFM SINT VSTE VVOS XLO XTKG
  • Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher

    After losing some value lately, a hammer chart pattern has been formed for ENDRA Life Sciences Inc. (NDRA), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

    Zacks Investment Research
Page data last updated 07/23/2025 17:42:00 UTC